These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7246449)

  • 1. Clinical, electrocardiographic and follow-up observations in patients having ventricular fibrillation during Holter monitoring. Role of quinidine therapy.
    Denes P; Gabster A; Huang SK
    Am J Cardiol; 1981 Jul; 48(1):9-16. PubMed ID: 7246449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes.
    Lewis BH; Antman EM; Graboys TB
    J Am Coll Cardiol; 1983 Sep; 2(3):426-36. PubMed ID: 6192159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease.
    Viskin S; Chorin E; Viskin D; Hochstadt A; Halkin A; Tovia-Brodie O; Lee JK; Asher E; Laish-Farkash A; Amit G; Havakuk O; Belhassen B; Rosso R
    Circulation; 2019 May; 139(20):2304-2314. PubMed ID: 30696267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
    J Am Coll Cardiol; 1985 Sep; 6(3):539-44. PubMed ID: 2411776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation with special reference to preceding arrhythmic events.
    Pratt CM; Francis MJ; Luck JC; Wyndham CR; Miller RR; Quinones MA
    J Am Coll Cardiol; 1983 Nov; 2(5):789-97. PubMed ID: 6630759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV; Grossbard CL; Graboys TB; Lown B
    Am J Cardiol; 1988 Nov; 62(14):18I-21I. PubMed ID: 2461071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsade de pointes due to quinidine: observations in 31 patients.
    Bauman JL; Bauernfeind RA; Hoff JV; Strasberg B; Swiryn S; Rosen KM
    Am Heart J; 1984 Mar; 107(3):425-30. PubMed ID: 6695683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodromal ventricular premature beats preceded by a diastolic wave.
    Ejvinsson G; Orinius E
    Acta Med Scand; 1980; 208(6):445-50. PubMed ID: 7468313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents.
    Belhassen B; Shapira I; Shoshani D; Paredes A; Miller H; Laniado S
    Circulation; 1987 Apr; 75(4):809-16. PubMed ID: 3829343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'.
    Bozic B; Uzelac TV; Kezic A; Bajcetic M
    Mini Rev Med Chem; 2018; 18(6):468-475. PubMed ID: 28685701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram.
    Kyriazis K; Bahlmann E; van der Schalk H; Kuck KH
    Europace; 2009 May; 11(5):665-6. PubMed ID: 19346290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of patients with malignant ventricular arrhythmias.
    Lown B; Graboys TB
    Am J Cardiol; 1977 May; 39(6):910-8. PubMed ID: 871114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome.
    Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH
    Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinidine for ventricular arrhythmias: value of electrophysiologic testing.
    DiMarco JP; Garan H; Ruskin JN
    Am J Cardiol; 1983 Jan; 51(1):90-5. PubMed ID: 6849270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden death in hospitalized patients: cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring.
    Panidis IP; Morganroth J
    J Am Coll Cardiol; 1983 Nov; 2(5):798-805. PubMed ID: 6630760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic antecedents of primary ventricular fibrillation. Value of the R-on-T phenomenon in myocardial infarction.
    El-Sherif N; Myerburg RJ; Scherlag BJ; Befeler B; Aranda JM; Castellanos A; Lazzara R
    Br Heart J; 1976 Apr; 38(4):415-22. PubMed ID: 57784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.